Clinical trial Recruiting at 2 sites Observational Ages 18 to 70

Pharmacist-led continuous glucose monitoring for people with prediabetes

Official title: Redefining Prediabetes Care: Pharmacist-Led Continuous Glucose Monitoring to Drive Lifestyle Change

Run by University of South Florida · NCT07529366 · Data updated 2026-11-12

Pharmacists will try continuous glucose monitoring to see if it improves blood sugar and health habits in adults with prediabetes.

More Prediabetes trials

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of South Florida
Academic / other
Locations2 sites (Tampa, Florida and 1 other locations)
StatusRecruiting
StartedOctober 6, 2026
Main results expectedJuly 31, 2027
Study endsJuly 31, 2027
Registry record updatedOctober 7, 2026
Trial IDNCT07529366 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 with prediabetes (HbA1c 5.7–6.4%), who have not used CGM in the prior 6 months and have a smartphone compatible with the Dexcom Stelo system, are the intended participants.

Probably not a fit

People with diagnosed diabetes, recent problematic hypoglycemia, pregnancy, planned dialysis, or no compatible smartphone are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational program uses pharmacist-led wearable continuous glucose monitoring (Dexcom Stelo) in adults with prediabetes and compares outcomes to a historical cohort without CGM. The primary metabolic endpoint is change in hemoglobin A1c at 12 weeks, and investigators will also compare CGM-derived glycemic metrics from baseline to the end of the wear period in the intervention group. Health behavior and quality-of-life changes will be measured with the Summary of Diabetes Self-Care Activities (SDSCA) and the SF-36 at baseline, week 4, and study end. Participants must be 18–70 years old, have prediabetes-range A1c, and a smartphone compatible with the Dexcom Stelo system.

Why it matters

Potential benefit: If successful, the program could help people with prediabetes lower average glucose levels and adopt healthier self-care behaviors earlier.

How similar studies have gone: Previous CGM studies in people with diabetes and at-risk adults have shown behavior change and improved glycemic metrics, but pharmacist-led CGM specifically in prediabetes remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adults 18-70 years of age
* prediabetes (HbA1c 5.7-6.4%)
* compatible smartphone with the Dexcom Stelo sensor system
* have not have worn a CGM in the last 6 months prior to enrollment

Exclusion Criteria:

* any of the following forms of diabetes: type 1 diabetes, type 2 diabetes, monogenic diabetes, cystic fibrosis-related diabetes, post- transplant diabetes, latent autoimmune diabetes
* problematic hypoglycemia in the prior 6 months \[defined as recurrent (more than one) level 2 hypoglycemic events (glucose \<54mg/dL ) that persist despite multiple attempts to adjust medication(s) and/or modify the diabetes/treatment plan or a history of one level 3 hypoglycemic event (glucose \<54mg/dL) characterized by altered mental and/or physical state requiring third-party assistance for treatment of hypoglycemia\]
* pregnant, or planning to become pregnant during the study time frame
* currently receiving or planned to receive dialysis during the study time frame - current use of systemic steroids for any condition
* a known allergy to medical grade adhesives,
* use of any CGM device in the past 6 months
* history of a diagnosed eating disorder
* current use of a second-generation antipsychotic at the time of consent (aripiprazole, asenapine, brexpiprazole, cariprazine, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone)
* subjects lacking capacity to provide informed consent

Where it's running

  • USF Health Department of Family Medicine - Morsani Center for Advanced Health Care
    Tampa, Florida, United States
    Recruiting
  • USF Health Department of Family Medicine - University Partnership Center
    Tampa, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Kevin Cowart, PharmD, MPH — University of South Florida
  • Study coordinator: Kevin Cowart, PharmD, MPH
  • Email: kcowart2@usf.edu
  • Phone: 813-974-5562

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.